- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Contact Pharm Exec Editors
Subscription Support
Contact MMHInfo@mmhgroup.com for subscription-related questions only.
Press Releases and News Announcements
Send press releases and other announcements relevant to the pharma c-suite to pharmexec@mjhlifesciences.com.
Submit Article and/or Podcast Proposals
Use this form to submit article/podcast proposals.
Editorial Staff (US)
Mike Hollan
Assistant Managing Editor
mhollan@mjhlifesciences.com
Michael Christel
Group Managing Editor
mchristel@mjhlifesciences.com
Miranda Schmalfuhs
Group Social Media Editor
mschmalfuhs@mjhlifesciences.com
Don Tracy
Associate Editor
dtracey@mjhlifesciences.com
Custom Projects Staff
Colleen Hall
Vice President, Content and Special Projects
Jeanne Linke
Managing Editor
Megan Manzano
Senior Editor
Shannon Stolz
Senior Editor
Additional Information
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
